Current Pharmacogenomics and Personalized Medicine

Formerly Current Pharmacogenomics

Ramón Cacabelos
Institute of Medical Science and Genomic Medicine


Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:14   Issue: 2
Pp: 65-65
Ari Hirvonen*
DOI: 10.2174/187569211402170424204837

Editorial: CPPM Onward and Upward: Global Personalized Medicine Guided by Responsible Innovation free to download

Volume:14   Issue: 2
Pp: 66-67
Adrian Llerena* and Vural Ozdemir
DOI: 10.2174/187569211402170424205258

DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy

Volume:14   Issue: 2
Pp: 68-73
Karimpanakkal C. Ajithkumar and Kannissery Pramod*
DOI: 10.2174/1875692115666170208121925

Impact of New Technologies on Pharmacogenomics

Volume:14   Issue: 2
Pp: 74-85
Maria Isidoro-Garcia*, Almudena Sanchez-Martin and Belen Garcia-Berrocal
DOI: 10.2174/1875692115666170214152152

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

Volume:14   Issue: 2
Pp: 86-105
Germana Castelli, Elvira Pelosi and Ugo Testa*
DOI: 10.2174/1875692115666170224094023

Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs

Volume:14   Issue: 2
Pp: 106-123
Upinder Kaur, Sankha S. Chakrabarti and Indrajeet S. Gambhir*
DOI: 10.2174/1875692115666170403101207

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

Volume:14   Issue: 2
Pp: 124-133
Assaad Y. Semaan, Kristin R. Delfino, Andrew C. Wilber, Thomas K. Mathews, Kathy J. Robinson, Laurent Brard and Shaheen R. Alanee*
DOI: 10.2174/1875692115666170126152349


Volume:14   Issue: 2
Pp: 134-134

DOI: 10.2174/187569211402170424211446